{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:51:00Z","timestamp":1791427860270,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030 _212244\/1"],"award-info":[{"award-number":["320030 _212244\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhep.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:15:50Z","timestamp":1788016550000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum HBsAg cannot distinguish cccDNA activity from integrated HBV DNA expression in chronic hepatitis B virus infection"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4774-9399","authenticated-orcid":false,"given":"Aleksei","family":"Suslov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-5266","authenticated-orcid":false,"given":"Matthias S.","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0259-8611","authenticated-orcid":false,"given":"Diego","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athimed","family":"El Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-977X","authenticated-orcid":false,"given":"Stefan","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-4894","authenticated-orcid":false,"given":"Markus H.","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.08.018_bib1","series-title":"WHO - global hepatitis report","year":"2017"},{"key":"10.1016\/j.jhep.2026.08.018_bib2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Collaboration GBoDLC","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2026.08.018_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2026.08.018_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.29509","article-title":"A research agenda for curing chronic hepatitis B virus infection","volume":"67","author":"Alter","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.08.018_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-med-080119-103356","article-title":"New therapeutics for hepatitis B: the road to cure","volume":"72","author":"Naggie","year":"2021","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jhep.2026.08.018_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41575-022-00649-z","article-title":"A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook","volume":"19","author":"Kramvis","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib7","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/HEP.0000000000000431","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference","volume":"78","author":"Ghany","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.08.018_bib8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"European association for the study of the L. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","author":"Cornberg","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited","volume":"66","author":"Cornberg","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/286535a0","article-title":"Integration of hepatitis B virus sequences and their expression in a human hepatoma cell","volume":"286","author":"Edman","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.08.018_bib11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","article-title":"Hepatitis B virus DNA integration: implications for diagnostics, therapy, and outcome","volume":"81","author":"Zoulim","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2026.08.018_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2021.04.051","article-title":"Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load","volume":"75","author":"Meier","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib14","article-title":"Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B","volume":"4","author":"van Buuren","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.08.018_bib15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.08.018_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","article-title":"Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo","volume":"67","author":"Allweiss","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.08.018_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184243","article-title":"Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment","volume":"135","author":"Taddese","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2026.08.018_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161818","article-title":"Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment","volume":"132","author":"Grudda","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2026.08.018_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/v9040075","article-title":"HBV DNA integration: molecular mechanisms and clinical implications","volume":"9","author":"Tu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2026.08.018_bib20","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1126\/science.3787251","article-title":"Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide","volume":"234","author":"Persing","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jhep.2026.08.018_bib21","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1073\/pnas.84.19.6909","article-title":"Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice","volume":"84","author":"Chisari","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2026.08.018_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00428227","article-title":"Detection of HBsAg containing cells in liver biopsies by different stains and classification of positively reacting ground-glass hepatocytes","volume":"384","author":"Borchard","year":"1979","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.jhep.2026.08.018_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/hep.1840080408","article-title":"Correlation of hepatocyte HBsAg expression with virus replication and liver pathology","volume":"8","author":"Hsu","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.08.018_bib24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/gutjnl-2013-305517","article-title":"HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability","volume":"63","author":"Kim","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.08.018_bib25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/liv.14171","article-title":"Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: the impact of hepatitis B and C viral replication","volume":"39","author":"Younossi","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.08.018_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.06.038","article-title":"Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: results of the PAGE-B cohort","author":"Papatheodoridis","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jvh.12402","article-title":"Hepatitis B reactivation in HBsAg-negative\/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis","volume":"22","author":"Mozessohn","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2026.08.018_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues","volume":"70","author":"Yip","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2020.11.003","article-title":"Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity","volume":"74","author":"Suslov","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1053\/j.gastro.2021.11.002","article-title":"Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: an international, multi-center, multi-ethnic cohort (RETRACT-B study)","volume":"162","author":"Hirode","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.08.018_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jhep.2026.03.030","article-title":"Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort","volume":"85","author":"Dongelmans","year":"2026","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02007-17","article-title":"Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via NTCP-dependent uptake of enveloped virus particles","volume":"92","author":"Tu","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2026.08.018_bib33","doi-asserted-by":"crossref","first-page":"8515","DOI":"10.1038\/s41467-025-63497-w","article-title":"Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance","volume":"16","author":"Harris","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.08.018_bib34","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1136\/gutjnl-2017-313811","article-title":"Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers","volume":"67","author":"Pfefferkorn","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.08.018_bib35","article-title":"HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers","volume":"5","author":"Roade","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.08.018_bib36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/liv.14298","article-title":"Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a","volume":"40","author":"Rinker","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.08.018_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/v13020210","article-title":"Hepatitis B virus DNA integration and clonal expansion of hepatocytes in the chronically infected liver","volume":"13","author":"Mason","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jhep.2026.08.018_bib38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jhep.2022.01.007","article-title":"Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels","volume":"76","author":"Sonneveld","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib39","doi-asserted-by":"crossref","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2026.08.018_bib40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.08.018_bib41","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gutjnl-2020-322571","article-title":"Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5\/6 complex and silencing of the viral genome in vivo","volume":"71","author":"Allweiss","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.08.018_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/gutjnl-2023-330644","article-title":"Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B","volume":"73","author":"Testoni","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.08.018_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2020.08.039","article-title":"Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B","volume":"74","author":"Pfefferkorn","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.08.018_bib44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2025.12.006","article-title":"Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond","volume":"84","author":"Sonneveld","year":"2026","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826028618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826028618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:27:30Z","timestamp":1791426450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826028618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"alternative-id":["S0168827826028618"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.08.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum HBsAg cannot distinguish cccDNA activity from integrated HBV DNA expression in chronic hepatitis B virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}